- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Di | VC funding in Europe falls short at early-stage investment hurdles | ||
| Di | Pentagon drops WuXi AppTec from Chinese military company list | ||
| Di | China's burgeoning novel medicines success presents opportunity for Europe | ||
| Di | Delix Therapeutics raises $100m for zalsupindole development | ||
| Di | Charles River agrees $470m deal for Frontage assets | ||
| Mo | Network Bio partners with Duke University on AI disease models | ||
| Mo | Bio-Thera gains Chinese approval for spondylitis and rheumatoid arthritis drug | ||
| Fr | FDA expands J&J's Rybrevant Faspro label with head and neck cancer approval | ||
| Fr | MHRA champions patient voices through new policy | ||
| Fr | Armada to combine with Brains Bioceutical in $750m deal | ||
| Fr | Alfasigma receives EC's expanded approval for filgotinib to treat axSpA | ||
| Do | Cordavis to stay in CVS Health after bifurcation of $117bn empire | ||
| Do | Big pharma-backed T-Therapeutics snags $133m to bring TCEs to clinic | ||
| Do | Evommune signs $1.1bn licence deal with Hinova for EVO570 | ||
| Do | PharmatrophiX and Circular partner on neurodegenerative drugs | ||
| 04.11. | Trump's healthcare plans under contention after Democrats' midterm landslide | ||
| 04.11. | Boehringer signs oncology deal with Sino Biopharm worth up to $7.4bn | ||
| 04.11. | AbbVie bolsters UK R&D presence, inks $1.38bn IBD deal with Nxera | ||
| 04.11. | GEBRO and Spektus sign collaboration for ActraFlex | ||
| 04.11. | FDA to review uniQure's BLA for Huntington's gene therapy | ||
| 03.11. | FDA calls for stronger potency upkeep in CGT manufacturing | ||
| 03.11. | AbbVie inks $757m migraine-focused deal with Brise Pharmaceuticals | ||
| 03.11. | Lonza to acquire five US manufacturing sites from Merck KGaA | ||
| 03.11. | Bavarian Nordic secures four-year UK vaccine supply deal | ||
| 02.11. | Fresenius and WuXi team up in 37-strong biosimilar development deal |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.